Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Ferguson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Letters|January 2, 2007
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cellsKaren L Morley, Peter J Ferguson, James Koropatnick
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2017
Synergistic Antiproliferative Activity of the RAD51 Inhibitor IBR2 with Inhibitors of Receptor Tyrosine Kinases and Microtubule ProteinPeter J Ferguson, Mark D Vincent, James Koropatnick
Tumori|October 3, 2015
Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalanPeter J Ferguson, Alexander Sykelyk, Rene Figueredo, et al.
Cancer Letters|November 7, 2008
Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifenePeter J Ferguson, Alayne R Brisson, James Koropatnick, et al.
Cancer Gene Therapy|April 8, 2003
A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistanceRandal W Berg, Peter J Ferguson, Mark D Vincent, et al.
Nutrition and Cancer|December 21, 2006
In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extractPeter J Ferguson, Elzbieta M Kurowska, David J Freeman, et al.
Molecular Therapy. Nucleic Acids|March 14, 2013
Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality"Mateusz Rytelewski, Peter J Ferguson, Saman Maleki Vareki, et al.
The Journal of Nutrition|June 3, 2004
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell linesPeter J Ferguson, Elzbieta Kurowska, David J Freeman, et al.
DNA and Cell Biology|March 25, 2008
ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell linesTracey L H Jason, Rene Figueredo, Peter J Ferguson, et al.
Oncotarget|June 19, 2015
siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabineChristine Di Cresce, Rene Figueredo, Mateusz Rytelewski, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Letters|January 2, 2007
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cellsKaren L Morley, Peter J Ferguson, James Koropatnick
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2017
Synergistic Antiproliferative Activity of the RAD51 Inhibitor IBR2 with Inhibitors of Receptor Tyrosine Kinases and Microtubule ProteinPeter J Ferguson, Mark D Vincent, James Koropatnick
Tumori|October 3, 2015
Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalanPeter J Ferguson, Alexander Sykelyk, Rene Figueredo, et al.
Cancer Letters|November 7, 2008
Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifenePeter J Ferguson, Alayne R Brisson, James Koropatnick, et al.
Cancer Gene Therapy|April 8, 2003
A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistanceRandal W Berg, Peter J Ferguson, Mark D Vincent, et al.
Nutrition and Cancer|December 21, 2006
In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extractPeter J Ferguson, Elzbieta M Kurowska, David J Freeman, et al.
Molecular Therapy. Nucleic Acids|March 14, 2013
Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality"Mateusz Rytelewski, Peter J Ferguson, Saman Maleki Vareki, et al.
The Journal of Nutrition|June 3, 2004
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell linesPeter J Ferguson, Elzbieta Kurowska, David J Freeman, et al.
DNA and Cell Biology|March 25, 2008
ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell linesTracey L H Jason, Rene Figueredo, Peter J Ferguson, et al.
Oncotarget|June 19, 2015
siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabineChristine Di Cresce, Rene Figueredo, Mateusz Rytelewski, et al.
Pageof 2